Goldman Sachs
ANGO icon

Goldman Sachs’s AngioDynamics ANGO Stock Holding History

Goldman Sachs’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.57M Sell
314,089
-2,300
-0.7% -$24.9K ﹤0.01% 4014
2025
Q4 		$4.06M Buy
316,389
+46,273
+17% +$571K ﹤0.01% 3936
2025
Q3 		$3.02M Buy
270,116
+71,446
+36% +$690K ﹤0.01% 4112
2025
Q2 		$1.97M Sell
198,670
-60,556
-23% -$593K ﹤0.01% 4190
2025
Q1 		$2.43M Buy
259,226
+22,658
+10% +$238K ﹤0.01% 3990
2024
Q4 		$2.17M Sell
236,568
-1,623
-0.7% -$11.9K ﹤0.01% 4204
2024
Q3 		$1.85M Buy
238,191
+32,361
+16% +$234K ﹤0.01% 4220
2024
Q2 		$1.25M Buy
205,830
+38,608
+23% +$238K ﹤0.01% 4300
2024
Q1 		$982K Sell
167,222
-27,285
-14% -$162K ﹤0.01% 4363
2023
Q4 		$1.52M Sell
194,507
-396,419
-67% -$2.75M ﹤0.01% 4121
2023
Q3 		$4.32M Buy
590,926
+96,923
+20% +$806K ﹤0.01% 3114
2023
Q2 		$5.15M Buy
494,003
+82,617
+20% +$795K ﹤0.01% 3086
2023
Q1 		$4.25M Sell
411,386
-26,490
-6% -$339K ﹤0.01% 3201
2022
Q4 		$6.03M Buy
437,876
+123,615
+39% +$1.72M ﹤0.01% 3005
2022
Q3 		$6.43M Buy
314,261
+69,888
+29% +$1.53M ﹤0.01% 2911
2022
Q2 		$4.73M Sell
244,373
-6,820
-3% -$140K ﹤0.01% 3188
2022
Q1 		$5.41M Sell
251,193
-213,245
-46% -$4.84M ﹤0.01% 3280
2021
Q4 		$12.8M Buy
464,438
+8,541
+2% +$236K ﹤0.01% 2539
2021
Q3 		$11.8M Buy
455,897
+227,357
+99% +$6.08M ﹤0.01% 2559
2021
Q2 		$6.2M Buy
228,540
+100,214
+78% +$2.45M ﹤0.01% 3148
2021
Q1 		$3M Sell
128,326
-20,543
-14% -$415K ﹤0.01% 3587
2020
Q4 		$2.28M Sell
148,869
-89,457
-38% -$1.14M ﹤0.01% 3631
2020
Q3 		$2.87M Buy
238,326
+140,178
+143% +$1.33M ﹤0.01% 3313
2020
Q2 		$998K Sell
98,148
-219,374
-69% -$2.26M ﹤0.01% 3954
2020
Q1 		$3.31M Sell
317,522
-81,921
-21% -$1.03M ﹤0.01% 2958
2019
Q4 		$6.39M Buy
399,443
+133,243
+50% +$2.03M ﹤0.01% 2767
2019
Q3 		$4.9M Buy
266,200
+160,732
+152% +$3.14M ﹤0.01% 2876
2019
Q2 		$2.08M Sell
105,468
-82,067
-44% -$1.67M ﹤0.01% 3524
2019
Q1 		$4.29M Buy
187,535
+72,719
+63% +$1.58M ﹤0.01% 3091
2018
Q4 		$2.31M Buy
114,816
+6,966
+6% +$144K ﹤0.01% 3439
2018
Q3 		$2.35M Sell
107,850
-1,293
-1% -$28.7K ﹤0.01% 3488
2018
Q2 		$2.43M Buy
109,143
+4,212
+4% +$86.1K ﹤0.01% 3510
2018
Q1 		$1.81M Sell
104,931
-14,399
-12% -$240K ﹤0.01% 3673
2017
Q4 		$1.98M Sell
119,330
-162,920
-58% -$2.78M ﹤0.01% 3808
2017
Q3 		$4.82M Sell
282,250
-47,912
-15% -$805K ﹤0.01% 3181
2017
Q2 		$5.35M Sell
330,162
-9,027
-3% -$143K ﹤0.01% 2994
2017
Q1 		$5.88M Buy
339,189
+55,549
+20% +$929K ﹤0.01% 2807
2016
Q4 		$4.79M Buy
283,640
+141,801
+100% +$2.36M ﹤0.01% 3093
2016
Q3 		$2.49M Buy
141,839
+112,558
+384% +$1.83M ﹤0.01% 3640
2016
Q2 		$421K Sell
29,281
-28,705
-50% -$359K ﹤0.01% 5013
2016
Q1 		$713K Buy
+57,986
New +$641K ﹤0.01% 4390
2015
Q4 		– Sell
-16,377
Closed -$216K – 7122
2015
Q3 		$216K Buy
16,377
+4,379
+36% +$66.1K ﹤0.01% 5944
2015
Q2 		$197K Sell
11,998
-5,369
-31% -$89.1K ﹤0.01% 6161
2015
Q1 		$309K Buy
17,367
+3,005
+21% +$55.9K ﹤0.01% 5611
2014
Q4 		$273K Sell
14,362
-143,357
-91% -$2.43M ﹤0.01% 5877
2014
Q3 		$2.16M Sell
157,719
-61,058
-28% -$871K ﹤0.01% 3860
2014
Q2 		$3.57M Buy
218,777
+52,860
+32% +$765K ﹤0.01% 3393
2014
Q1 		$2.61M Buy
165,917
+24,535
+17% +$400K ﹤0.01% 3718
2013
Q4 		$2.43M Buy
141,382
+58,219
+70% +$896K ﹤0.01% 3876
2013
Q3 		$1.1M Buy
83,163
+24,780
+42% +$292K ﹤0.01% 4518
2013
Q2 		$659K Buy
+58,383
New +$621K ﹤0.01% 4718

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Goldman Sachs's ANGO Position: Q1 2026 in Review

Goldman Sachs reduced its AngioDynamics (ANGO) stake by 0.73% in Q1 2026, selling an estimated $24.9K and leaving 314,089 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

Goldman Sachs first reported a position in ANGO in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.8M in Q4 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Goldman Sachs held 314,089 shares of AngioDynamics worth $3.57M as of Q1 2026.
  • Goldman Sachs sold 2,300 AngioDynamics shares in Q1 2026, an estimated $24.9K.
  • AngioDynamics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4014 holding.
  • Goldman Sachs first reported a position in AngioDynamics in Q2 2013 and has held it in 51 quarters since.
  • Goldman Sachs's AngioDynamics position peaked at $12.8M in Q4 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.